MarketPulse — Real-Time Financial News & Market Analysis

Long-acting HIV injectable therapy significantly outperforms daily pills in Phase 3 trial, showing lower failure rates and improved outcomes for patients with adherence challenges.

Varonis Systems faces class action lawsuit after stock plunged 48.67% on October 29 following missed revenue projections and weak customer conversions disclosure.

BellRing Brands faces securities lawsuit alleging false statements about financial performance and growth. Class action covers November 2024 through August 2025 for affected investors.

Paysafe shareholders can join class action lawsuit until April 7, 2026, alleging the company made false statements and failed to disclose material issues affecting investors.

MarketWise rejected a $17.25 per share acquisition bid, citing undervaluation. The company accelerates standalone growth with strong Q4 results and 13% dividend yield.

Monument & Cathedral withdraws $17.25 per share bid for MarketWise. The company remains independent, citing strong Q4 performance with 42% billings growth and $45M operating cash flow.

Class action lawsuit filed against Klarna for allegedly making false statements about risks associated with loan losses in its September 2025 IPO.

Banks gain from tech rotation and favorable conditions, but large banks trade at premium valuations. Regional banks offer better value with similar tailwinds.

Deere shifts toward AI and autonomous farming tech to address labor shortages. Stock up 30% since early 2026, positioning for sector recovery projected through multi-year growth.

ImmunityBio shares surged 41% after Europe approved its bladder cancer therapy ANKTIVA, enabling commercialization across 30+ nations and opening significant revenue opportunities.

TMC pursues ocean-floor mining for battery metals but faces unproven technology, regulatory hurdles, and continued losses before potential revenue generation.

Molson Coors beat EPS expectations but missed revenue forecasts, declining 2.7% year-over-year. Stock fell 7% on weak guidance and revenue concerns.

Kenvue shares rose 2.55% after beating Q4 earnings estimates with $0.27 EPS versus expected $0.22, prompting analyst upgrades ahead of its planned merger with Kimberly-Clark.

Etsy shares surge 14.8% after-hours on agreement to sell Depop fashion marketplace to eBay for $1.2 billion, allowing capital reallocation to core operations.

Tech stocks surge as S&P 500 gains 0.56% on AI infrastructure optimism. Nvidia leads rally following Meta partnership announcement for data center chips.

Equinox Gold launches shareholder returns program with inaugural quarterly dividend of $0.015 per share and 5% share buyback authorization, reflecting improved financial strength.

REGENXBIO faces class action lawsuit over allegedly false safety disclosures for gene therapy RGX-111. FDA clinical hold triggered 17.8% stock drop after adverse trial findings.

Alamos Gold raises quarterly dividend 60% to $0.04/share, driven by record $352M free cash flow and confidence in strong earnings outlook.

Kinross Gold raises annual dividend 14% to $0.16 per share, marking its second increase in months with 33% cumulative growth since Q3 2025.

Kyndryl Holdings faces securities lawsuit alleging false financial statements and inadequate internal controls, with shareholders from August 2024-February 2026 eligible to join the class action.